Literature DB >> 1825896

Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese.

J Woo1, E Lau, C W Lam, R Kay, R Teoh, H Y Wong, W Y Prall, L Kreel, M G Nicholls.   

Abstract

We analyzed the serum concentrations of lipids and lipoproteins and the prevalence of other risk factors in a case-control study of 304 consecutive Chinese patients with acute stroke (classified as cerebral infarction, lacunar infarction, or intracerebral hemorrhage) and 304 age- and sex-matched controls. For all strokes we identified the following risk factors: a history of ischemic heart disease, diabetes mellitus, or hypertension; the presence of atrial fibrillation or left ventricular hypertrophy; a glycosylated hemoglobin A1 concentration of greater than 9.1%; a fasting plasma glucose concentration 3 months after stroke of greater than 6.0 mmol/l; a serum triglyceride concentration 3 months after stroke of greater than 2.1 mmol/l; and a serum lipoprotein(a) concentration of greater than 29.2 mg/dl. We found the following protective factors: a serum high density lipoprotein-cholesterol concentration of greater than 1.59 mmol/l and a serum apolipoprotein A-I concentration of greater than or equal to 106 mg/dl. The patterns of risk factors differed among the three stroke subtypes. When significant risk factors were entered into a multiple logistic regression model, we found a history of hypertension, a high serum lipoprotein(a) concentration, and a low apolipoprotein A-I concentration to be independent risk factors for all strokes. The attributable risk for hypertension was estimated to be 24% in patients aged greater than or equal to 60 years. In this population, in which cerebrovascular diseases are the third commonest cause of mortality, identification of risk factors will allow further studies in risk factor modification for the prevention of stroke.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825896     DOI: 10.1161/01.str.22.2.203

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

Review 1.  The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients.

Authors:  C Sarti; M Kaarisalo; J Tuomilehto
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

2.  Lipoprotein(a)

Authors:  J Scott
Journal:  BMJ       Date:  1991-09-21

3.  Correlation between biochemical indicators of blood lipid with cerebral vascular diseases.

Authors:  Dongmei Wang; Jun Hu; Qiao Ma; Jiarui Ma; Binjian Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 4.  Lipoprotein(a): searching for a function.

Authors:  P C Harpel; M Poon; X Zhang; M B Taubman
Journal:  Trans Am Clin Climatol Assoc       Date:  1996

5.  Serum lipids in young patients with ischaemic stroke: a case-control study.

Authors:  J F Albucher; J Ferrieres; J B Ruidavets; B Guiraud-Chaumeil; B P Perret; F Chollet
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

6.  Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study.

Authors:  E Lindenstrøm; G Boysen; J Nyboe
Journal:  BMJ       Date:  1994-07-02

Review 7.  Apolipoprotein A1, B levels, and their ratio and the risk of a first stroke: a meta-analysis and case-control study.

Authors:  Hongli Dong; Wei Chen; Xiangyu Wang; Fuhua Pi; Yubin Wu; Shaojie Pang; Yuqing Xie; Fangfang Xia; Qingying Zhang
Journal:  Metab Brain Dis       Date:  2015-09-12       Impact factor: 3.584

8.  Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation.

Authors:  D G Jamieson; D C Usher; D J Rader; E Lavi
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

9.  The role of fasting versus non-fasting triglycerides in ischemic stroke: a systematic review.

Authors:  Christopher Leonards; Martin Ebinger; Jana Batluk; Uwe Malzahn; Peter Heuschmann; Matthias Endres
Journal:  Front Neurol       Date:  2010-10-25       Impact factor: 4.003

10.  Reduced serum levels of triglyceride, very low density lipoprotein cholesterol and apolipoprotein B in Parkinson's disease patients.

Authors:  Qiang Wei; Honghao Wang; Yanghua Tian; Fangcheng Xu; Xianwen Chen; Kai Wang
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.